Revvity, Inc. announced the launch of Revvity Transcribe AI, an optical character recognition (OCR) service designed to convert handwritten text on test request forms into a digitized format.
Revvity Transcribe AI addresses the need for laboratories to quickly and accurately process test request forms. In many laboratories, this is manual work that is time-consuming, prone to errors, and for which talent is hard to recruit. Based on initial internal data, the solution improves overall data entry workflow speed by 40 percent, including data validation.
While beneficial for a range of applications, this service is especially valuable for newborn screening (NBS) laboratories and is compatible with the EVOYA platform, Revvity’s NBS software solution. Public screening labs process hundreds of handwritten dried blood spot (DBS) test cards every day, and by deploying Revvity Transcribe AI, the manual data entry resource can instead be made available for other tasks within the laboratory.
Revvity Transcribe AI was introduced at the 2024 APHL Newborn Screening Symposium, October 20-24, in Omaha, Nebraska.
